Literature DB >> 12857052

Fulminating onset type 1 diabetes with positivity for anti-GAD antibody and elevated pancreatic exocrine enzyme concentrations.

Toshio Kahara1, Toshinari Takamura, Hitoshi Ando, Masaru Sakurai, Tsuguhito Ota, Tsuguho Misaki, Sakae Oba, Masaharu Iguchi, Kazutoshi Komori, Ken-ichi Kobayashi.   

Abstract

A 52-year-old man was admitted to our hospital for diabetic ketoacidosis. On admission, Hb(A1c) was 6.5%, anti-GAD antibody 10.3 U/ml, serum amylase 144 IU/l, lipase 169 U/l and elastase-I 1,000 ng/dl. There were no abdominal symptoms, and abdominal CT showed unremarkable findings. He was treated with intensive insulin therapy. After 1 month, urinary excretion of C-peptide was 3.8 microg/day. Serum pancreatic exocrine enzyme concentrations returned to normal after 3 months. After 10 months, anti-GAD antibody had become negative, but insulin therapy was still needed for glycemic control. This report concerns a case of autoimmune fulminating onset type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857052     DOI: 10.2169/internalmedicine.42.517

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Elevated pancreatic enzymes, IgM, soluble interleukin-2 receptor in anti-GADab(+) type 1 diabetes.

Authors:  Hidekatsu Yanai; Sumie Moriyama
Journal:  World J Diabetes       Date:  2011-05-15

2.  The clinical utility of comprehensive measurement of autoimmune disease-related antibodies in patients with advanced solid tumors receiving immune checkpoint inhibitors: a retrospective study.

Authors:  N Izawa; H Shiokawa; R Onuki; K Hamaji; K Morikawa; H Saji; H Ohashi; S Kasugai; N Hayakawa; T Ohara; Y Sunakawa
Journal:  ESMO Open       Date:  2022-03-02

3.  Autoimmune pancreatitis: the emerging role of serologic biomarkers.

Authors:  John W Wiley; Massimo Pietropaolo
Journal:  Diabetes       Date:  2009-03       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.